Ginkgo Biloba Prevention Trial in Older Individuals

PHASE3CompletedINTERVENTIONAL
Enrollment

3,069

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

April 30, 2008

Study Completion Date

July 31, 2011

Conditions
DementiaAlzheimer's Disease
Interventions
DRUG

Ginkgo biloba

120mg twice a day

DRUG

Placebo

One pill twice daily

Trial Locations (5)

15213

University of Pittsburgh, Pittsburgh

21205

Johns Hopkins University, Baltimore

22908

University of Pittsburgh/University of Virginia, Charlottesville

95817

University of California, Davis, Sacramento

27157-1063

Wake Forest University School of Medicine, Winston-Salem

All Listed Sponsors
collaborator

Office of Dietary Supplements (ODS)

NIH

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

National Institute on Aging (NIA)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

National Center for Complementary and Integrative Health (NCCIH)

NIH

NCT00010803 - Ginkgo Biloba Prevention Trial in Older Individuals | Biotech Hunter | Biotech Hunter